home / stock / rhhby / rhhby news


RHHBY News and Press, Roche Holding Ltd ADR

Stock Information

Company Name: Roche Holding Ltd ADR
Stock Symbol: RHHBY
Market: OTC
Website: roche.com

Menu

RHHBY RHHBY Quote RHHBY Short RHHBY News RHHBY Articles RHHBY Message Board
Get RHHBY Alerts

News, Short Squeeze, Breakout and More Instantly...

RHHBY - Roche Falters In A Key Breast Cancer Readout

2026-03-11 11:44:40 ET Topline Summary There is a lot you can say about Roche Holding (RHHBY; RHHBF), and their status as a big pharma is many, many disease areas, not just oncology that I would normally find in my wheelhouse. This article will not focus on the Roche stock performan...

RHHBY - Regeneron: Fairly Valued Now After A Stellar Upswing

2026-03-11 09:47:27 ET Regeneron Pharmaceuticals, Inc. ( REGN ) is a well-established biotech company based in Tarrytown, NY, that has had a phenomenal journey since its founding in 1988, but most clearly – for shareholders – since it reached an inflection point in 201...

RHHBY - Harbor Health Care ETF Q4 2025 Portfolio Review

2026-03-11 08:18:00 ET The following segment was excerpted from the Harbor Health Care ETF Q4 2025 Commentary . ... Read the full article on Seeking Alpha For further details see: Harbor Health Care ETF Q4 2025 Portfolio Review

RHHBY - Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline Transcript

2026-03-09 18:47:57 ET Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline March 9, 2026 12:00 PM EDT... Read the full article on Seeking Alpha For further details see: Roche Holding AG (RHHBY) Discusses Phase III Study Result...

RHHBY - Roche stock falls after breast cancer combo therapy fails in trial

2026-03-09 06:21:00 ET More on Roche Holding, Pfizer Pfizer: Obesity Hype And Vaccine Policy Shocks Pfizer's Portfolio Renewal In Progress - High Yields For The Patient Pfizer's Quiet Cash Comeback Roche continues to expect tariff impact on diagnostics despit...

RHHBY - Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer

persevERA Breast Cancer study did not meet the primary objective of a statistically significant improvement in progression-free survival, but a numerical improvement was observed Giredestrant plus palbociclib was well tolerated and adverse events were consistent with the known safety prof...

RHHBY - 2 Underrated Weight Loss Stocks to Buy Now

2026-03-08 08:20:00 ET Investors who want to capitalize on the growing weight loss market might be tempted to turn to the current leaders in the field, Eli Lilly and Novo Nordisk . Both companies are worth serious consideration, in my view, but other drugmakers could also offer in...

RHHBY - Roche continues to expect tariff impact on diagnostics despite U.S. deal

2026-03-07 11:37:01 ET More on Roche Holding Roche Holding AG (RHHBY) Shareholder/Analyst Presentation Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript Roche succeeds in mid-stage trial for...

RHHBY - FDA vaccine chief to leave the agency again

2026-03-07 07:41:45 ET More on Pfizer, Johnson & Johnson, etc. Pfizer: Obesity Hype And Vaccine Policy Shocks The Sun Will Shine On Moderna Again - Initiating With A Buy Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom J&J subsidi...

RHHBY - Pharma giants pressed by Senate Democrats over Trump pricing deals

2026-03-06 10:45:02 ET More on Pfizer, Merck, etc. Pfizer: Obesity Hype And Vaccine Policy Shocks AbbVie: Stabilizes Near $233 While Testing Resistance Pfizer's Portfolio Renewal In Progress - High Yields For The Patient China approves Pfizer’s GLP-1 d...

Next 10